Enhance Drug Formulation and Delivery Strategies to Ensure Patient Compliance to Biologic Therapies
World Congress’ Drug Delivery Biologics Formulation will provide a forum for formulation professionals to strategize solutions to challenges in biologics development and discuss various formulation and device-based approaches for designing patient centric biologic drugs and explore innovations in biologic drug delivery. Co-located with the World Congress’ Drug Delivery innovations in Biologics Summit, attendees will be able to benefit from 30+ presentations within a two track event focused on biologic formulation strategies, novel biologics delivery approaches, technologies and partnerships to develop innovative formulation and delivery strategies of biologics.
The PDF brochure for the Drug Delivery Biologics Formulation is in production. Request it now and our Customer Service team will contact you once the brochure becomes available.
Top Reasons to Attend:
- Develop novel formulation strategies to enhance the design and delivery of high dose biologic formulations
- Understand the regulatory environment impacting biologics drug development
- Explore the opportunities in protein and peptide based biologics to ensure optimum stability, bioavailability, safety and patient compliance
- Understand how to maintain molecular stability and predict protein stability
- Discover key strategies for developing parenteral protein combination products
- Ensure patient centricity in drug formulation to achieve a competitive advantage through ensuring quality and enhancing the patient experience
Participating Organizations
Benefit from one-on-one meetings, corporate branding and relationship building by participating as an active corporate supporter and sponsor. World Congress offers various levels of support and sponsorship opportunities. To learn more contact:
Chris Karassik
Manager, Business Development
Phone: 781-939-2419
Email: [email protected]
Call for Papers
Submit Abstract for Presentations
Drug Delivery Biologics Formulation is now accepting abstract submissions for 2018!